Search results for "Quality control"

Evaluation of DR and CR digital mammography systems based on phantom and breast dosimetry.

2006

Digital mammography has been progressively introduced in screening centers, since recent evolution of CR and DR detectors. However, it is questionable which exposure conditions would be more suitable when these techniques are applied, in order to reduce the glandular breast doses, as they are related with induced carcinogenesis. Several exposures have been performed in CR and DR mammography units for comparing absorbed doses during quality control assessments and during screening, diagnosis and treatment. In the first case, the CIRS11A mammographic phantom has been used with standard exposure conditions (28 kV, AEC mode with blackening +0, 50:50 glandularity and 4.5 compressed breast thickn…

Unmet needs and challenges in gastric cancer: The way forward

2014

AbstractAlthough the incidence of gastric cancer has fallen steadily in developed countries over the past 50years, outcomes in Western countries remain poor, primarily due to the advanced stage of the disease at presentation. While earlier diagnosis would help to improve outcomes for patients with gastric cancer, better understanding of the biology of the disease is also needed, along with advances in therapy. Indeed, progress in the treatment of gastric cancer has been limited, mainly because of its genetic complexity and heterogeneity. As a result, there is an urgent need to apply precision medicine to the management of the disease in order to ensure that individuals receive the most appr…

Quantifying the health impacts of outdoor air pollution: useful estimations for public health action

2013

According to WHO,1 health impact assessment (HIA) is A combination of procedures, methods and tools used to evaluate the potential health effects of a policy, programme or project. Using qualitative, quantitative and participatory techniques, HIA aims to produce recommendations that will help decision makers and other stakeholders make choices about alternatives and improvements to prevent disease/injury, and to actively promote health. The typical procedural steps in HIA include screening, scoping, assessment of health effects, recommending alternatives and mitigations, reporting and monitoring.2 Each step helps predict or foresee potential effects of policy decisions on a population's hea…

The role of the reporting framework MIATA within current efforts to advance immune monitoring

2014

The European directive on traditional herbal medicinal products: friend or foe for plant-based therapies?

2012

Analysis of Urine Samples Containing Cardiovascular Drugs by Micellar Liquid Chromatography with Fluorimetric Detection

1999

A simple direct injection chromatographic procedure with fluorimetric detection is successfully applied to the determination of mixtures of 4 diuretics (amiloride, bendroflumethiazide, piretanide, and triamterene) and 6 beta-blockers (acebutolol, atenolol, labetalol, metoprolol, nadolol, and propranolol), which are usually administered in combinations for the treatment of hypertension, in urine samples. The procedure makes use of C18 columns and micellar mobile phases of sodium dodecyl sulphate (SDS), propanol, and phosphate buffer at pH 3. The adequate resolution of most drugs is obtained with a chemometrics approach where the retention is modeled as a first step using the retention factor…

Analysis of the implementation of ISO 9000 quality assurance systems

2000

Examines the literature relating to the implementation of quality assurance systems and then uses a questionnaire to a number of organisations and consultants to compare “practice” with “theory”. Analyses the implementation process for quality assurance systems designed to meet the requirements of the ISO 9000 standard to identify the role of the different “actors” to find out which factors facilitate the implementation or make it more difficult. Suggests that the primary motivation for introducing ISO 9000 systems is to improve image and reputation rather than processes.

Quality System for Production Software as Tool for Monitoring and Improving Organization KPIs

2013

In this paper we propose a solution as support for quality systems for production software. The motivation behind this study was to reduce that cost in the production area caused by gaps in the quality of the production software. Our proposal: QSPS (Quality System for Production Software) is offering support in the "vulnerable points" of these quality systems which usually generate nonconformities and have proved to be difficult or impossible to control. QSPS is a method in seven steps or modules that integrates also software tools, templates, checklists, evaluating tools elaborated complying to products, process and system quality standards. If other analyzed methods like: Scrum, XP, Fuzzy…

Quality Indicators in Reference to the Evaluation of the Quality Management of Services in Local Public Administration

2014

Abstract The paper proposes to show evidence in measures of quality through quantification of the level of current performance of an organization, like local public administration, in accordance with performance standards. The evaluation of quality measures the difference between the expected performance and the actual performance, to identify and improve the quality of the local public administration. Standards of performance could be set for different dimensions of quality. For example: the quality of managing documents, the products, processes and services requires the gathering and analysis of information, set in measuring terms. In a few cases the measuring of quality as percentage of …

Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency.

2012

SummaryIndividuals with inherited factor VII (FVII) deficiency display bleeding phenotypes ranging from mild to severe, with 30% of patients having always been asymptomatic (non-bleeding). In 626 FVII-deficient individuals, by analysing data from the International Factor VII (IF7) Registry and the Seven Treatment Evaluation Registry (STER), we determined whether bleeding type at disease presentation and FVII coagulant activity (FVIIc) predict ensuing bleeds. At disease presentation/diagnosis, 272 (43.5%) individuals were non-bleeding, 277 (44.2%) had minor bleeds, and 77 (12.3%) had major bleeds. During a median nine-year index period (IP) observation, 87.9% of non-bleeding individuals at p…